# Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing

> **NCT00116285** · PHASE1 · COMPLETED · sponsor: **Allergy Therapeutics** · enrollment: 12 (—)

## Conditions studied

- Type I Hypersensitivity

## Interventions

- **BIOLOGICAL:** Ragweed MATA MPL

## Key facts

- **NCT ID:** NCT00116285
- **Lead sponsor:** Allergy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 12 (—)
- **Last updated:** 2010-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116285, "Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00116285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*